Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
New Technology to Store Vaccination History in the Body
The Massachusetts Institute of Technology (MIT) News reported that researchers at the university have developed a way to record a person’s vaccination history and store the data in a pattern of dye, invisible to the naked eye, by infusing it under the skin at the same time the vaccine is given.1 The idea is to […]
Half of Americans Will Be Diagnosed With Cancer by 2030
Cancer is an “abnormal growth of cells.” That is perhaps the most succinct description of the disease, which is really more a group of diseases since there are more than 100 types of cancer. Cancer cells are malignant—meaning that they can invade and spread to different parts of the body, forming solid tumors (masses of […]
